ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

by | Jun 10, 2025 | Clinical Trials | 0 comments

​ Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema

Interventions: Drug: ATI-045; Drug: Placebo

Sponsors: Aclaris Therapeutics, Inc.

Recruiting Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema
Interventions: Drug: ATI-045; Drug: Placebo
Sponsors: Aclaris Therapeutics, Inc.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *